Venous thromboembolism (VTE) is a major cause of maternal morbidity during pregnancy
and the postpartum period. However, because there is a lack of adequate study data …

Introduction: Anticoagulants are among the most frequently prescribed medications in the
United States. Racial and ethnic disparities in incidence and outcomes of thrombotic …

Background Significant changes occur in the coagulation and fibrinolytic systems during
pregnancy and puerperium in the plasma levels. However, reference ranges based on …

Background Pregnancy is a hypercoagulable state associated with an increased risk of
venous thrombosis, which begins during the first trimester, but the exact time of onset is …

Venous thromboembolism (VTE) refers to a blood clot that starts in a vein. The risk of
developing VTE is highest after major surgery or a major injury, or when someone has heart …

Background Pregnant women are at increased risk of venous thrombosis compared to non-
pregnant women. Epidemiological and laboratory data suggest that hypercoagulability …

Background Pregnant and puerperal women are high-risk populations for developing
venous thromboembolism (VTE). Plasma D-dimer (DD) is of good value in the diagnosis of …

Background Venous thromboembolism often develops after surgery and childbirth, resulting
in death in some cases. Although early deep vein thrombosis (DVT) detection can predict …

Pregnancy is a hypercoagulable state associated with an increased risk of venous
thrombosis. Thrombomodulin (TM)-modified thrombin generation is a promising laboratory …

Aim. To estimate the effectiveness of the thrombin generation assay (TGA) in identifying high
thrombogenic risk in pregnant women. Material and methods. The study comprised 30 …